253 related articles for article (PubMed ID: 11893792)
1. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.
Côté HC; Brumme ZL; Craib KJ; Alexander CS; Wynhoven B; Ting L; Wong H; Harris M; Harrigan PR; O'Shaughnessy MV; Montaner JS
N Engl J Med; 2002 Mar; 346(11):811-20. PubMed ID: 11893792
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.
Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S73-9. PubMed ID: 14986278
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA and nucleoside toxicity.
Casademont J; Miró O; Cardellach F
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125711
[No Abstract] [Full Text] [Related]
4. Mitochondrial DNA and nucleoside toxicity.
Chariot P; Bourokba N; Brivet F
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12124414
[No Abstract] [Full Text] [Related]
5. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
6. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA and nucleoside toxicity.
Rastegar DA
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125710
[No Abstract] [Full Text] [Related]
8. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
[TBL] [Abstract][Full Text] [Related]
9. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
Banas B; Kost BP; Goebel FD
Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626
[TBL] [Abstract][Full Text] [Related]
10. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R
Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367
[TBL] [Abstract][Full Text] [Related]
11. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
[TBL] [Abstract][Full Text] [Related]
13. Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?
de Mendoza C; Sanchez-Conde M; Ribera E; Domingo P; Soriano V
AIDS Rev; 2004; 6(3):169-80. PubMed ID: 15595434
[TBL] [Abstract][Full Text] [Related]
14. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
[TBL] [Abstract][Full Text] [Related]
16. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
17. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
[TBL] [Abstract][Full Text] [Related]
19. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
